IMARC Group, a leading market research company, has recently released a report titled “Carrier Screening Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027.” The study provides a detailed analysis of the industry, including the global carrier screening market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
How big is the carrier screening market?
The global carrier screening market size reached US$ 1.5 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 2.9 Billion by 2027, exhibiting a growth rate (CAGR) of 11.4% during 2022-2027.
Market Outlook:
Carrier screening is a category of genetic test that is used to determine if a person is a carrier of genetic or specific autosomal recessive diseases. It is a pre-symptomatic and predictive testing solution that provides life-lasting information about the reproductive risks of an individual and their chances of having a child with genetic disorders. The screening involves the testing of the samples of saliva, cheek tissue, or blood to detect the presence of an abnormal gene for disorders such as sickle cell anemia, cystic fibrosis, and Tay-Sachs disease. These samples are then screened using molecular and biochemical processes based on polymerase chain reaction (PCR), deoxyribonucleic acid (DNA) sequencing, and microarray technologies.
Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.
Request to Get the Sample Report:
https://www.imarcgroup.com/carrier-screening-market/requestsample
Market Trends:
The growing consumer awareness regarding early disease detection and prevention and the inflating consumer per capita income are some of the factors providing an impetus to the market growth. Apart from this, the rising awareness regarding carrier screening and the burgeoning prevalence of fetal chromosomal abnormalities and genetic disorders are bolstering the market growth. Furthermore, the emergence of advanced diagnostic tests and increasing research and development (RD) activities in biotechnology and bioinformatics are accelerating the market growth. Moreover, the development of next-generation sequencing (NGS) techniques by key players and rising investments in clinical trials are creating a positive outlook for the market.
Competitive Analysis and Segmentation:
The competitive landscape of the global carrier screening market has been studied in the report with the detailed profiles of the key players operating in the market.
Major Players Covered:
- Fulgent Genetics (NASDAQ: FLGT)
- Gene By Gene Ltd. (MyDNA) (OTCMKTS: GNTLF)
- Illumina Inc. (NASDAQ: ILMN)
- Invitae Corporation (NYSE: NVTA)
- MedGenome Labs Ltd.
- Myriad Genetics Inc. (NASDAQ: MYGN)
- Natera Inc. (NASDAQ: NTRA)
- OPKO Health Inc. (NASDAQ: OPK)
- Quest Diagnostics (NYSE: DGX)
- Sema4 (NASDAQ: SMFR)
- Thermo Fisher Scientific Inc. (NYSE: TMO)
Key Market Segmentation:
The report has segmented the global carrier screening market on the basis of type, medical condition, technology, end user and region.
Breakup by Type:
- Expanded Carrier Screening
- Targeted Disease Carrier Screening
Breakup by Medical Condition:
- Pulmonary Conditions
- Hematological Conditions
- Neurological Conditions
- Others
Breakup by Technology:
- DNA Sequencing
- Polymerase Chain Reaction
- Microarrays
- Others
Breakup by End User:
- Hospitals and Clinics
- Reference Laboratories
- Others
Geographical Analysis:
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East and Africa
Explore Full Report Description At: https://www.imarcgroup.com/carrier-screening-market
Key Highlights of the Report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
